Globe Life (TMJ) Q3 2026 Earnings Report

The call was broadly constructive. Management reported growth in operating income, total and health premiums, book value, sales activity, investment income, capital flexibility, and shareholder returns, while also outlining favorable claims experience, AI initiatives, Bermuda-related cash flow opportunities, and 2027 growth guidance. These positives were partially offset by a 2% decline in GAAP net income, lower 2026 EPS guidance, direct-to-consumer and American Income recruiting challenges, lower life and health margin metrics, CMS-related claims disruption, and significant volatility and losses at the early-stage Evri business.

For full year 2026, Globe Life expects total premium revenue growth to be around 6.5%, life premium revenue growth between 2.5% to 2.75%, life underwriting margin of 44% to 45% of premium, health premium revenue growth around 15%, health underwriting margin growth in the range of 4.0% to 4.5%, health underwriting margin of 22% to 24% of premium, administrative expenses at approximately 7.3% of premium, American Income average producing agent count down around 5%, Liberty National up around 9%, Family Heritage up around 5%, net life sales approximately flat at American Income, up around 10% at Liberty National and down around 9% at Direct to Consumer, and net health sales down around 7% at Liberty National, up approximately 10% at Family Heritage and up around 45% at United American; net operating earnings per diluted share are expected in the range of $15.35 to $15.65, normalized EPS growth approximately 8%, net investment income growth around 4.5%, required interest growth around 3.5%, excess investment income growth of 10% to 11%, average yield on total long term investments approximately 5.51%, and share repurchases in the range of $725 million to $775 million. For full year 2027, the company expects net operating earnings per diluted share in the range of $16.10 to $17.10, representing an increase of 7% at the midpoint, total premium revenue growth of 6% to 8%, life premium revenue growth of 4%, health premium revenue growth of 13% to 15%, life underwriting margin of 42% to 45% of premium, health underwriting margin of 20% to 24%, health underwriting margin dollar growth of 7% to 9%, net investment income growth in the range of 2.5% to 3.5%, required interest growth in the range of 3.5% to 4.0%, average yield on total long term investments between 5.50% to 5.55%, parent excess cash flows approximately $850 million to $950 million, and a cash conversion ratio in the range of 70% to 75% of net operating income; 2027 sales growth is expected to be mid- to high-single-digit at American Income, low double digit at Liberty National and low single digit at Direct to Consumer for net life sales, and low double digit at Liberty National and Family Heritage and high single digit at United American for net health sales.